Elevation Oncology, Inc. Quarterly Debt-to-equity in % from Q1 2022 to Q2 2024

Taxonomy & unit: ratio: %
Description: Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary: Elevation Oncology, Inc. quarterly Debt-to-equity history and growth rate from Q1 2022 to Q2 2024.
Elevation Oncology, Inc. Debt-to-equity for the quarter ending June 30, 2024 was 50.6 %, a 34.2% decline year-over-year.

Debt-to-equity, Quarterly (%)

Debt-to-equity, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date
Q2 2024	50.6	-26.3	-34.2%	Jun 30, 2024
Q1 2024	54	-5.61	-9.41%	Mar 31, 2024
Q4 2023	68.6	+34.1	+98.7%	Dec 31, 2023
Q3 2023	75.4	+56.5	+298%	Sep 30, 2023
Q2 2023	76.9	+67.8	+745%	Jun 30, 2023
Q1 2023	59.6	+54	+965%	Mar 31, 2023
Q4 2022	34.5			Dec 31, 2022
Q3 2022	19			Sep 30, 2022
Q2 2022	9.1			Jun 30, 2022
Q1 2022	5.59			Mar 31, 2022

* An asterisk sign (*) next to the value indicates that the value is likely invalid.